« Back
Home /
Gadobutrol

Gadobutrol

Item no.	HY-16217-100mg
Manufacturer	MedChem Express
CASRN	770691-21-9
Amount	100 mg
Quantity options	100 mg 10mM/1mL 10 mg 200 mg 50 mg 5 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Clone	N/A
Specific against	other
Purity	99.58
Formula	C18H31GdN4O9
Citations	[1]Cheng KT. Gadobutrol. Molecular Imaging and Contrast Agent Database (MICAD)<br/>[2] B Hofmann, et al. Gadolinium neutron capture therapy (GdNCT) of melanoma cells and solid tumors with the magnetic resonance imaging contrast agent Gadobutrol. Invest Radiol. 1999 Feb;34(2):126-33.<br/>[3]Takashi Watanabe, et al. Gadobutrol enhances T1-weighted MRI of nerve cells. Toxicol Lett. 2019 Jun 15;308:17-23.
Smiles	OC[C@H]1[N]23[Gd+3]([N]4(C5)CC3)([N]6(C7)CC4)([OH][C@@H]1CO)([O-]C5=O)([O-]C8=O)([O-]C7=O)[N](CC6)(C8)CC2
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	ZK 135079
Available
Product Description	Gadobutrol (Gd-DO3A-butrol; ZK 135079) is a nonionic paramagnetic macrocyclic gadolinium-based contrast agent that can be used for magnetic resonance imaging (MRI)[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
MolecularWeight	604.71
Clinical Information	Launched
Manufacturers Research Area	Cancer
Solubility	H2O : 20 mg/mL (ultrasonic)
Target	Biochemical Assay Reagents
Manufacturers Target	Biochemical Assay Reagents
Manufacturers Pathway	Others
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-16217-100mg-safety-datasheet.pdf